Logilet was founded by a group of Cambridge alumni. Our proprietary technologies combine both digital microfluidics and real-time polymerase chain reaction (real-time PCR) together to produce a true point of care DNA detection platform. Logilet’s innovative platform offers unique solutions to accelerate the availability of reliable and accurate advanced molecular diagnostics at the point of care.
At Eksigent, a part of Sciex Separations and AB Sciex, we believe that conventional HPLC systems, built using yesterday’s technology, need to be reinvented to meet today’s needs. This led to our development of microflow and nanoflow fluid delivery technologies that take HPLC beyond conventional limits and achieve performance levels that today’s applications demand.
We have worked on microfluidics since 2000, incorporating chip-based components such as flow cells, filters, traps and columns into its products. Compared with nanoLC columns constructed from fused silica tubing with sintering particle end-frits, Eksigent cHiPLC® columns are more robust and easier to handle and connect without introducing dead volumes.
We provide solutions for syndromic testing, such as the QIAstat-Dx syndromic testing system. Disease area panels, including the QIAstat-Dx Respiratory SARS-CoV-2 Panel, utilize our powerful sample and assay technologies, to deliver a true Sample to Insight solution. Syndromic panel testing redefines ease of use and expands reporting capabilities, ensuring result integrity.
